Core Financial Statements From 2010 to 2025

CLB Stock  USD 11.23  0.38  3.50%   
Core Laboratories' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core Laboratories' valuation are provided below:
Gross Profit
102.4 M
Profit Margin
0.0541
Market Capitalization
508.7 M
Enterprise Value Revenue
1.2873
Revenue
517.8 M
We have found one hundred twenty available fundamental signals for Core Laboratories NV, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Core Laboratories NV prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. As of May 27, 2025, Market Cap is expected to decline to about 694.1 M. In addition to that, Enterprise Value is expected to decline to about 831.7 M

Core Laboratories Total Revenue

617.87 Million

Check Core Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.7 M, Interest Expense of 10.2 M or Selling General Administrative of 34.9 M, as well as many indicators such as Price To Sales Ratio of 2.65, Dividend Yield of 0.0022 or PTB Ratio of 6.3. Core financial statements analysis is a perfect complement when working with Core Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Core Stock
Check out the analysis of Core Laboratories Correlation against competitors.

Core Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets553.5 M590.4 M581.8 M
Pretty Stable
Short and Long Term Debt Total219.5 M180.1 M258.6 M
Very volatile
Other Current Liabilities49.2 M31.1 M48.3 M
Slightly volatile
Total Current Liabilities100.8 M97.6 M104.6 M
Pretty Stable
Property Plant And Equipment Net121.7 M153.6 M137.9 M
Slightly volatile
Net Debt186.6 M161 M235.4 M
Very volatile
Retained Earnings193.2 M150.3 M190.5 M
Slightly volatile
Accounts Payable36.4 M34.5 M37.8 M
Pretty Stable
Cash30 M19.2 M18 M
Very volatile
Non Current Assets Total327.7 M363.8 M360.1 M
Slightly volatile
Cash And Short Term Investments30 M19.2 M18 M
Very volatile
Net Receivables129.7 M127.4 M132.7 M
Pretty Stable
Common Stock Shares Outstanding40.7 M47.7 M45.1 M
Very volatile
Liabilities And Stockholders Equity553.5 M590.4 M581.8 M
Pretty Stable
Non Current Liabilities Total267 M235.1 M327.6 M
Very volatile
Inventory40.5 M59.4 M45 M
Slightly volatile
Other Current Assets25.6 M20.7 M26.3 M
Very volatile
Total Liabilities367.8 M332.7 M432.3 M
Very volatile
Property Plant And Equipment Gross491.3 M467.9 M200.4 M
Slightly volatile
Total Current Assets225.8 M226.6 M221.7 M
Very volatile
Short Term Debt13.9 M10.7 M10.4 M
Slightly volatile
Intangible Assets6.1 M6.4 M9.4 M
Pretty Stable
Common Stock Total Equity1.1 M1.4 M1.2 M
Slightly volatile
Common Stock446.5 K470 KM
Slightly volatile
Other Liabilities66.4 M86.9 M81 M
Slightly volatile
Other Assets236.2 M224.9 M86.2 M
Slightly volatile
Long Term Debt224.1 M126.1 M235.3 M
Pretty Stable
Property Plant Equipment126.1 M181 M135.3 M
Slightly volatile
Current Deferred Revenue11.1 M9.3 M11.3 M
Slightly volatile
Good Will117.6 M89.5 M147.6 M
Slightly volatile
Warrants7.1 MM8.7 M
Slightly volatile
Non Current Liabilities Other19.7 M20.7 M41 M
Very volatile
Long Term Debt Total211.3 M155.1 M245.8 M
Slightly volatile
Capital Surpluse63.7 M117.6 M60 M
Slightly volatile
Deferred Long Term Asset Charges81.3 M77.4 M37.4 M
Slightly volatile
Short and Long Term Debt239.9 M204.7 M256.8 M
Slightly volatile
Long Term Investments4.2 M5.1 M3.5 M
Slightly volatile
Cash And Equivalents15.8 M17.7 M14.9 M
Slightly volatile
Net Invested Capital276 M378.1 M352.4 M
Slightly volatile
Net Working Capital122 M129 M107.9 M
Slightly volatile
Capital Stock773.1 K470 KM
Slightly volatile
Capital Lease Obligations48.3 M54 M68.7 M
Slightly volatile

Core Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.7 M15 M20.9 M
Very volatile
Selling General Administrative34.9 M38.6 M41.4 M
Pretty Stable
Total Revenue617.9 M523.8 M665.5 M
Slightly volatile
Gross Profit168.6 M88.4 M181.5 M
Slightly volatile
Other Operating Expenses494.5 M465.3 M526.9 M
Pretty Stable
Operating Income55.6 M58.6 M132.8 M
Slightly volatile
Cost Of Revenue449.2 M435.5 M483.9 M
Pretty Stable
Total Operating Expenses45.3 M29.8 M43 M
Very volatile
Interest Income9.8 M10.4 M12 M
Slightly volatile
Reconciled Depreciation15.8 M15 M21.8 M
Slightly volatile
Non Recurring97.8 M110 M119.9 M
Slightly volatile

Core Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow41.2 M43.4 M104.3 M
Slightly volatile
Begin Period Cash Flow29.5 M15.1 M25.1 M
Slightly volatile
Depreciation21.7 M15 M21 M
Very volatile
Capital Expenditures16.7 M13 M19.8 M
Slightly volatile
Total Cash From Operating Activities110 M56.4 M127.4 M
Slightly volatile
End Period Cash Flow30 M19.2 M18 M
Very volatile
Stock Based Compensation3.6 M3.8 M16.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.651.54974.1178
Slightly volatile
Dividend Yield0.00220.00230.0138
Pretty Stable
Days Sales Outstanding90.2388.736876.1324
Pretty Stable
Free Cash Flow Yield0.05610.05340.0352
Very volatile
Operating Cash Flow Per Share1.741.20242.8099
Slightly volatile
Stock Based Compensation To Revenue0.00680.00720.0233
Very volatile
Capex To Depreciation1.170.87130.9378
Slightly volatile
EV To Sales2.891.8574.4752
Slightly volatile
Free Cash Flow Per Share1.40.92462.3709
Slightly volatile
ROIC0.150.08080.215
Slightly volatile
Inventory Turnover12.527.33111.1537
Slightly volatile
Days Of Inventory On Hand27.7249.788735.7048
Slightly volatile
Payables Turnover9.9812.604612.8789
Pretty Stable
Sales General And Administrative To Revenue0.05320.07370.0642
Slightly volatile
Capex To Revenue0.04570.02490.0296
Pretty Stable
Cash Per Share0.460.40850.3882
Pretty Stable
POCF Ratio17.4614.396525.1631
Very volatile
Interest Coverage4.54.734112.5954
Slightly volatile
Capex To Operating Cash Flow0.440.2310.2322
Slightly volatile
PFCF Ratio19.6618.72233.038
Pretty Stable
Days Payables Outstanding33.1228.957828.9504
Very volatile
EV To Operating Cash Flow19.2617.251428.2648
Pretty Stable
EV To Free Cash Flow23.5622.434837.6188
Slightly volatile
Intangibles To Total Assets0.260.17930.3341
Very volatile
Current Ratio2.662.32212.1701
Pretty Stable
Receivables Turnover3.684.11334.8565
Slightly volatile
Graham Number8.028.997111.4613
Slightly volatile
Capex Per Share0.340.27780.4391
Slightly volatile
Revenue Per Share9.4911.170214.5711
Slightly volatile
Interest Debt Per Share3.494.1055.8115
Very volatile
Debt To Assets0.30.30510.4158
Very volatile
Short Term Coverage Ratios82.2978.3880.9762
Slightly volatile
Operating Cycle128139112
Slightly volatile
Days Of Payables Outstanding33.1228.957828.9504
Very volatile
Price To Operating Cash Flows Ratio17.4614.396525.1631
Very volatile
Price To Free Cash Flows Ratio19.6618.72233.038
Pretty Stable
Operating Profit Margin0.140.11180.1763
Slightly volatile
Long Term Debt To Capitalization0.380.33350.5747
Pretty Stable
Total Debt To Capitalization0.410.41690.6026
Pretty Stable
Return On Capital Employed0.210.11880.2775
Slightly volatile
Ebit Per Revenue0.140.11180.1763
Slightly volatile
Quick Ratio2.171.71341.7151
Pretty Stable
Dividend Paid And Capex Coverage Ratio3.973.78342.2603
Pretty Stable
Net Income Per E B T0.540.68330.777
Very volatile
Cash Ratio0.320.19630.1809
Very volatile
Cash Conversion Cycle95.2311083.5369
Slightly volatile
Operating Cash Flow Sales Ratio0.120.10760.1639
Slightly volatile
Days Of Inventory Outstanding27.7249.788735.7048
Slightly volatile
Days Of Sales Outstanding90.2388.736876.1324
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.480.7690.7628
Slightly volatile
Cash Flow Coverage Ratios0.380.3130.4965
Slightly volatile
Fixed Asset Turnover5.673.41165.0128
Slightly volatile
Capital Expenditure Coverage Ratio3.614.32825.5932
Slightly volatile
Price Cash Flow Ratio17.4614.396525.1631
Very volatile
Debt Ratio0.30.30510.4158
Very volatile
Cash Flow To Debt Ratio0.380.3130.4965
Slightly volatile
Price Sales Ratio2.651.54974.1178
Slightly volatile
Asset Turnover1.210.88731.1477
Slightly volatile
Gross Profit Margin0.20.16870.2452
Slightly volatile

Core Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap694.1 M730.6 M2.3 B
Slightly volatile
Enterprise Value831.7 M875.5 M2.5 B
Slightly volatile

Core Fundamental Market Drivers

Forward Price Earnings19.7628
Cash And Short Term Investments19.2 M

Core Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Core Laboratories Financial Statements

Core Laboratories stakeholders use historical fundamental indicators, such as Core Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Core Laboratories' assets and liabilities are reflected in the revenues and expenses on Core Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Core Laboratories NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue9.3 M11.1 M
Total Revenue523.8 M617.9 M
Cost Of Revenue435.5 M449.2 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.05 
Capex To Revenue 0.02  0.05 
Revenue Per Share 11.17  9.49 
Ebit Per Revenue 0.11  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out the analysis of Core Laboratories Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.896
Dividend Share
0.04
Earnings Share
0.59
Revenue Per Share
11.046
Quarterly Revenue Growth
(0.05)
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.